Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-09
2010-10-05
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S491000
Reexamination Certificate
active
07807705
ABSTRACT:
Compounds and methods for treating cancer and inducing apoptosis in unwanted rapidly proliferating cells. The compounds are shown in formula I:wherein X is hydroxyl or amino; Y is carboxyl or sulfonyl; R1, R2, R3, and R4can be the same or different and are selected from hydrogen, halogen, methoxy, trifluoromethyl, hydroxyl and combinations thereof, R5, R6, and R7may be the same or different and are selected from hydrogen, chloro, bromo, nitro, phenyl, amino, methoxy, and combinations thereof, and derivatives or metabolites thereof.
REFERENCES:
patent: 6800655 (2004-10-01), Jong et al.
patent: 7078427 (2006-07-01), Jong et al.
patent: 2005/0043385 (2005-02-01), Kiplin et al.
patent: 1490671 (1977-11-01), None
patent: WO9850357 (1998-11-01), None
patent: WO2004048330 (2004-06-01), None
patent: WO2004055026 (2004-07-01), None
Kondo et al, Heterocycles (1996), vol. 42(1), pp. 105-108, .http://www.heterocycles.jp/pfiles/pdf.php/COM-95-S31.pdf?article=6317.
Kutschy, et al. Tetrahedron (1998), vol. 54, pp. 3549-3566.
International Search Report for PCT/US08/63323; mailed Oct. 13, 2008.
Aggarwal et al., “Molecular targets and anticancer potential of indole-3-carbinol and its derivatives”, Cell Cycle 4: p. 1201-1215 (2005).
Allen et al., “Entry into 6-methoxy-D(+)-tryptophans. Stereospecific synthesis of 1-benzenesulfonyl-6-methoxy-D(+)-tryptophan ethyl ester”, Synthetic Communications, vol. 22, No. 14, p. 2077-2102 (1992).
Brandi et al., “A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines”, Cancer Res. 63: p. 4028-4036 (2003).
Chinni et al., “Indole-3-carbinol (13C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells”, Oncogene 20: p. 2927-2936 (2001).
Chinni et al., “Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells”, Clin Cancer Res. 8: p. 1228-1236 (2002).
Chintharlapalli et al., “1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl) methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells”, Cancer Res. 64: p. 5994-6001 (2004).
Chintharlapalli et al., “1,1-Bis (3'-indolyl)-1-(p-substituted phenyl) methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1”, Mol Pharmacol 68: p. 1782-1792 (2005).
Contractor et al., “A novel ring-substituted diindolymethane, 1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia”, Cancer Res 65: p. 2890-2898 (2005).
De Kruif et al., “Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro”, Chem Biol Interact, 80: p. 303-315 (1991).
Dropinski et al., “Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists”, Bioorg Med Chem Lett 15: p. 5035-5038 (2005).
Gribble et al., “Syntheses and Diels-Alder cycloaddition reactions of 4H-furo[3,4-b] indoles. A regiospecific Diels-Alder synthesis of ellipticine”, J of Organic Chemistry, vol. 57, No. 22 p. 5878-5891 (1992).
Grose et al., “Oligomerization of indole-3-carbinol in aqueous acid”, Chem Res Toxicol 5: p. 188-193 (1992).
Henke et al., “Synthesis and biological activity of a novel series of indole-derived PPARgamma agonists”, Bioorg Med Chem Lett 9: p. 3329-3334.
Howells et al., “Inhibition of phosphatidylinositol 3-kinase/protein kinase B signaling is not sufficient to account for indole-3-carbinol-induced apoptosis in some breast and prostate tumor cells”, Clin Cancer Res 11: p. 8521-8527 (2005).
Hsu et al., “Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells”, Carcinogenesis 26: p. 1896-1904 (2005).
Kassouf et al., “Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl) methanes: a new class of peroxisome proliferator-activated receptor gamma agonists”, Cancer Res 66: p. 412-418 (2006).
Kim et al., “Targets for indole-3-carbinol in cancer prevention”, J Nutr Biochem 16: p. 65-73 (2005).
Kutschy et al., “New Synthesis of Indole Phytoalexins and related compounds”, Tetrahedron, vol. 54, No. 14, p. 3349-3566 (1998).
Manson, M., “Inhibition of survival signaling by dietary polyphenols and indole-3-carbinol”, Eur. J Cancer 41: p. 1842-1853 (2005).
Nachshon-Kedmi et al., “Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells”, Food Chem Toxicol 41: p. 745-752 (2003).
Qin et al., “A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl) methanes”, Mol Cancer Ther., 3: p. 247-259 (2004).
Sarkar et al., “Indole-3-Carbinol and prostate cancer,” J. Nutr., pp. 3493S-3498S (2004).
Weng et al., “A potent indole-3-carbinol-derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells” Cancer Research vol. 67, No. 16 p. 7815-7824 (2007).
Chen Ching-Shih
Wang Dasheng
Weng Jing-Ru
Calfee Halter & Griswold LLP
Saeed Kamal A
The Ohio State University Research Foundation
LandOfFree
Potent indole-3-carbinol-derived antitumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potent indole-3-carbinol-derived antitumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potent indole-3-carbinol-derived antitumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177819